KBC Group
MIRM icon

KBC Group’s Mirum Pharmaceuticals MIRM Stock Holding History

KBC Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108K Hold
1,268
– – ﹤0.01% 1338
2026
Q2 		$148K Hold
1,268
– – ﹤0.01% 1175
2026
Q1 		$117K Hold
1,268
– – ﹤0.01% 1234
2025
Q4 		$100K Hold
1,268
– – ﹤0.01% 1278
2025
Q3 		$93K Hold
1,268
– – ﹤0.01% 1311
2025
Q2 		$65K Sell
1,268
-699
-36% -$31.1K ﹤0.01% 1468
2025
Q1 		$89K Buy
+1,967
New +$92.7K ﹤0.01% 1544

Other funds holding MIRM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

KBC Group's MIRM Position: Q3 2026 in Review

KBC Group held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 1,268 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

KBC Group first reported a position in MIRM in Q1 2025 and has held it in 7 quarters since. The position peaked at $148K in Q2 2026. 127 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • KBC Group held 1,268 shares of Mirum Pharmaceuticals worth $108K as of Q3 2026.
  • KBC Group left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1338 holding.
  • KBC Group first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • KBC Group's Mirum Pharmaceuticals position peaked at $148K in Q2 2026.
  • 127 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.